Get complete Patent Opposition Report for Hospira

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Hospira's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3046603Mar 13, 2024Fail-Safe Drug Infusion Therapy System1
EP2766014Jul 18, 2018Methods Of Treating Pediatric Patients Using Dexmedetomidine1
EP2648520Apr 11, 2018Dexmedetomidine Premix Formulation1